Partnership Announcement: DIGIPHARM + ENGENE
We are proud to announce that we have partnered with EnGene.
What is EnGene?
EnGene was founded in 2014 as an official spinoff from the Department of Biosystems Science and Engineering, ETH Zurich. With representatives in Amsterdam, Basel, Washington DC and Zurich; enGene provides statistical data analysis and quantitative modeling for healthcare related projects. In addition, they also provide statistical consulting services across various disciplines for clients ranging from academia to industry.
“Our partnership with enGene is crucial to realizing the lofty aspirations for our Insights platform. enGene will contribute to the development of computational statistical algorithms for the real time analysis of genomic data, automated analysis of data derived from patient medical records and supporting HTA statistical analyses. The vastly experienced team bring many years of technical expertise that can only benefit our platforms and the Digipharm ecosystem” Ahmed Abdulla, Founder — Digipharm
“Supporting innovative projects and working with Digipharm is something that we are very excited about. Digipharm will be aggregating several sources of very rich data and we hope to play a pivotal part in better understanding this data for the benefit of all stakeholders in healthcare’ Federico Felizzi,
Our partnership with enGene is crucial to realizing the lofty aspirations for our Insights platform. enGene will contribute to the development of computational statistical algorithms for the real time analysis of genomic data in combination with data derived from patient medical records. The vastly experienced team bring many years of technical expertise that can only benefit our platforms and the Digipharm ecosystem.
We look forward to working together to make our vision of a more balanced, fair ecosystem across the healthcare industry a reality.
What is Digipharm?
Our solutions aim to accelerate the much needed restructuring of healthcare delivery systems from a ‘fee for service’ to a value-based approach. Digipharm is developing the world’s first smart contract platform for flexible pricing of healthcare technology and treatment provision, the world’s first ‘live’ real world evidence database and the ability to reward patients for contributing their data. Digipharm utilize innovative blockchain technology to overcome barriers to patient access, reduce costs for all stakeholders and drive value improvement
For more information, visit our website and connect with us socially:
Website: https://digipharm.ch/
Facebook: https://www.facebook.com/digipharmteam/
Twitter: https://twitter.com/DigipharmTeam
Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ
Reddit: https://www.reddit.com/r/Digipharm
LinkedIn: https://www.linkedin.com/company/digipharm/
